Breaking News

Thursday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
On The Fly	Rising High: Exclusive talk with biotech company Tryp Therapeutics » 11:59 05/19/22 05/19 11:59 05/19/22 11:59 GDNSF Goodness Growth $1.42 / -0.05 (-3.40%) , ZYNE Zynerba / + , TCNNF Trulieve Cannabis $14.37 / -0.135 (-0.93%) , TLRY Tilray $4.94 / +0.15 (+3.13%) , IGC India Globalization Capital / + , GTBIF Green Thumb Industries $11.67 / -0.52 (-4.27%) , CANN General Cannabis / + , CRON Cronos Group $3.48 / +0.155 (+4.66%) , CGC Canopy Growth $5.89 / +0.3 (+5.37%) , CTST CannTrust / + , CVSI CV Sciences / + , ACB Aurora Cannabis $3.08 / +0.175 (+6.02%) , RLMD Relmada Therapeutics $21.30 / -0.3 (-1.39%) , CMPS Compass Pathways $8.59 / +0.36 (+4.37%) , ATAI Atai Life Sciences $4.07 / +0.125 (+3.17%) , TRYPF Tryp Therapeutics / + In this edition of… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZYNE TRYPF TLRY TCNNF RLMD IGC GTBIF GDNSF CVSI CTST CRON CMPS CGC ATAI ACB ZYNE Zynerba / + 05/16/22 Zynerba expects cash to fund operations into second half of 2023 05/11/22 Zynerba presents long-term safety, efficacy data of Zygel 05/02/22 Zynerba presents long-term safety, efficacy data of Zygel 04/18/22 Tela Bio appoints D. Taylor Ocasio as general counsel TRYPF Tryp Therapeutics / + 12/22/21 Tryp Therapeutics receives FDA confirmation to proceed with Phase 2a study TLRY Tilray $4.94 / +0.15 (+3.13%) 05/12/22 Tilray announces expansion of Good Supply's cannabis portfolio 04/12/22 HEXO, Tilray enter agreement for strategic alliance 04/12/22 Tilray enters agreement with HEXO related to Senior Secured Convertible Note 04/06/22 Tilray subsidiary Manitoba Harvest partners with Whole Foods Market TCNNF Trulieve Cannabis $14.37 / -0.135 (-0.93%) 03/22/22 Tilt appoints Lynn Ricci as VP, investor relations, corporate communications 12/28/21 Trulieve appoints Steve White as president, Nicole Stanton as general counsel 12/28/21 Trulieve Cannabis acquires PurpleMed Healting Center in Arizona 11/29/21 Trulieve Cannabis issues first inaugural ESG report RLMD Relmada Therapeutics $21.30 / -0.3 (-1.39%) 04/29/22 Relmada Therapeutics announces publication of REL-1017 preclinical study 02/23/22 Relmada Therapeutics announces results from REL-1017 HAP study 12/22/21 Relmada Therapeutics: REL-1017 Phase 2 results published in AJOP IGC India Globalization Capital / + 12/08/21 India Globalization Capital says IGC-AD1 ph 1 trial provided 'valuable insight' 12/02/21 India Globalization Capital presents findings from Phase 1 trial of IGC-AD1 GTBIF Green Thumb Industries $11.67 / -0.52 (-4.27%) 05/02/22 Green Thumb announces internet availability of proxy materials for 2022 meeting 04/11/22 Green Thumb Industries to open RISE Mankato on April 14 03/11/22 Green Thumb Industries announces departure of Moore from board of directors 02/08/22 Green Thumb Industries appoints Dorri McWhorter to board of directors GDNSF Goodness Growth $1.42 / -0.05 (-3.40%) 02/28/22 Goodness Growth launches full line of cannabis flower in Minnesota 02/01/22 Verano Holdings to acquire Goodness Growth in $413M all-share transaction CVSI CV Sciences / + 03/08/22 CV Sciences adds +PlusCBD Relief Softgels to its Wellness line 01/11/22 CV Sciences launches +PlusCBD Pain Relief topicals 01/05/22 CV Sciences announces new distribution agreement with GNC CTST CannTrust / + 01/06/22 CannTrust reports implementation of CCAA plan, settlement of lawsuits CRON Cronos Group $3.48 / +0.155 (+4.66%) 03/21/22 Cronos Group founder Mike Gorenstein returns as CEO 03/01/22 Cronos Group announces planned exit of Peace Naturals Campus in Ontario 02/18/22 Cronos Group announces strategic realignment for $20M-$25M in savings 02/18/22 Cronos Group completes Audit Committee evaluation CMPS Compass Pathways $8.59 / +0.36 (+4.37%) 05/09/22 Compass Pathways to fund study of COMP360 psilocybin in autistic adults 05/03/22 Compass Pathways announces data on COMP360 psilocybin therapy 04/20/22 Compass Pathways partners with One Mind for Rising Star Awards 03/24/22 Compass Pathways, partners to launch psychedelic research facility CGC Canopy Growth $5.89 / +0.3 (+5.37%) 05/18/22 Canopy Growth announces plans to acquire Jetty Extracts 04/26/22 Canopy Growth expects to generate savings of $100M-$150M within 12-18 months 04/26/22 Canopy Growth announces cost reduction initiatives including headcount reduction 03/31/22 Canopy Growth appoints Judy Hong as CFO, Jonathan Di Tosto as COO ATAI Atai Life Sciences $4.07 / +0.125 (+3.17%) 03/30/22 Atai Life Sciences reports Q4 net loss $88.9M vs. $86.6M a year ago 02/01/22 IntelGenx receives third loan tranche from Atai Life Sciences 01/27/22 Atai Life Sciences to partner with Dalriada 01/12/22 atai Life Sciences' IND for PCN-101 approved by FDA ACB Aurora Cannabis $3.08 / +0.175 (+6.02%) 05/18/22 Aurora Cannabis receives EU-GMP certification for facility in Germany 05/12/22 Aurora Cannabis raises expense savings target to C$150M-C$170M 03/22/22 Aurora Cannabis to acquire Thrive Cannabis for $38M 02/10/22 Aurora Cannabis reaffirms goal of adjusted EBITDA profitability by 1H2023 GDNSF ZYNE TCNNF TLRY IGC GTBIF CANN CRON CGC CTST CVSI ACB RLMD CMPS ATAI TRYPF GDNSF Goodness Growth $1.42 / -0.05 (-3.40%) 05/12/22 Canaccord Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord 04/01/22 Alliance Global Partners Senate remains the hurdle for MORE Act, says Alliance Global Partners 02/01/22 Craig-Hallum Goodness Growth downgraded to Hold from Buy at Craig-Hallum 11/11/21 Canaccord Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord ZYNE Zynerba / + 06/25/21 Alliance Global Partners Cannabis selloff brings buying opportunities, says Alliance Global TCNNF Trulieve Cannabis $14.37 / -0.135 (-0.93%) 05/12/22 Alliance Global Partners Trulieve Cannabis price target lowered to C$50 from C$60 at Alliance Global Partners 03/31/22 Canaccord Trulieve Cannabis price target lowered to C$65 from C$70 at Canaccord 03/30/22 Alliance Global Partners Trulieve Cannabis price target lowered to C$60 from C$76 at Alliance Global Partners TLRY Tilray $4.94 / +0.15 (+3.13%) 05/02/22 Alliance Global Partners Tilray price target lowered to $5.50 from $8 at Alliance Global Partners 04/20/22 Barclays Tilray price target lowered to $4.50 from $8.50 at Barclays 04/06/22 MKM Partners Tilray margins contracted despite cost savings, says MKM Partners 04/06/22 Benchmark Tilray fiscal Q3 results 'disappointing,' says Benchmark IGC India Globalization Capital / + GTBIF Green Thumb Industries $11.67 / -0.52 (-4.27%) 05/05/22 Alliance Global Partners Green Thumb price target lowered to C$38 from C$40 at Alliance Global 05/05/22 Craig-Hallum Green Thumb Industries price target lowered to $25 from $35 at Craig-Hallum 05/05/22 Needham Green Thumb Industries price target lowered to $26 from $33 at Needham CANN General Cannabis / + CRON Cronos Group $3.48 / +0.155 (+4.66%) 05/11/22 CIBC CIBC upgrades Cronos to buy on 'multiple reasons for optimism' 05/11/22 Canaccord Cronos upgraded to Hold on operational improvements at Canaccord 05/11/22 CIBC Cronos Group upgraded to Outperformer from Neutral at CIBC 05/11/22 Canaccord Cronos Group upgraded to Hold from Sell at Canaccord CGC Canopy Growth $5.89 / +0.3 (+5.37%) 05/20/22 Alliance Global Partners Canopy Growth price target lowered to C$8 from C$11 at Alliance Global Partners 04/04/22 Morgan Stanley Constellation Brands price target lowered to $294 from $299 at Morgan Stanley 03/22/22 Barclays Canopy Growth downgraded to Underweight from Equal Weight at Barclays CTST CannTrust / + CVSI CV Sciences / + ACB Aurora Cannabis $3.08 / +0.175 (+6.02%) 05/16/22 CIBC Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC 05/13/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald 02/11/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald RLMD Relmada Therapeutics $21.30 / -0.3 (-1.39%) 05/09/22 Oppenheimer Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer 12/20/21 SVB Leerink Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink 11/17/21 Mizuho Relmada Therapeutics initiated with a Buy at Mizuho 09/30/21 Jefferies Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study CMPS Compass Pathways $8.59 / +0.36 (+4.37%) 02/28/22 Canaccord Compass Pathways price target lowered to $78 from $80 at Canaccord 11/11/21 Roth Capital Atai Life Sciences initiated with a Buy at Roth Capital 11/09/21 Citi Citi says Compass Pathways selloff overdone, ups price target to $70 11/09/21 Cantor Fitzgerald Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald ATAI Atai Life Sciences $4.07 / +0.125 (+3.17%) 05/17/22 Citi Atai Life Sciences price target lowered to $22 from $26 at Citi 04/01/22 Canaccord Atai Life Sciences price target lowered to $27 from $28 at Canaccord 03/31/22 RBC Capital Atai Life Sciences price target lowered to $9 from $12 at RBC Capital 11/30/21 Fly Intel: Top five analyst initiations TRYPF Tryp Therapeutics / + 08/26/21 Ladenburg Tryp Therapeutics initiated with a Buy at Ladenburg ZYNE TLRY TCNNF RLMD GTBIF CVSI CRON CMPS CGC ATAI ACB ZYNE Zynerba / + 05/16/22 Zynerba reports Q1 EPS (21c), consensus (23c) 03/01/22 Zynerba reports Q4 EPS (22c), consensus (26c) TLRY Tilray $4.94 / +0.15 (+3.13%) 04/06/22 Tilray reports Q3 EPS 9c vs. ($1.03) last year 01/10/22 Tilray reports Q2 revenue $155M vs. $129M last year TCNNF Trulieve Cannabis $14.37 / -0.135 (-0.93%) 05/12/22 Trulieve Cannabis reiterates 2022 revenue view $1.3B-$1.4B 05/12/22 Trulieve Cannabis reports Q1 adjusted EPS 1c vs. 30c last year RLMD Relmada Therapeutics $21.30 / -0.3 (-1.39%) 05/05/22 Relmada Therapeutics reports Q1 EPS ($1.40), consensus ($1.27) 03/23/22 Relmada Therapeutics reports Q4 EPS ($1.80), consensus ($1.83) GTBIF Green Thumb Industries $11.67 / -0.52 (-4.27%) 03/01/22 Green Thumb Industries reports Q4 EPS 10c vs. 11c last year CVSI CV Sciences / + 05/16/22 CV Sciences reports Q1 EPS (3c) vs. (2c) last year CRON Cronos Group $3.48 / +0.155 (+4.66%) 05/10/22 Cronos Group reports Q1 EPS (9c), consensus (8c) 03/01/22 Cronos Group reports 2021 EPS ($1.07), consensus (47c) 02/18/22 Cronos Group reports Q3 EPS 21c, consensus (10c) CMPS Compass Pathways $8.59 / +0.36 (+4.37%) 05/10/22 Compass Pathways reports Q1 EPS (50c), consensus (67c) 02/24/22 Compass Pathways reports Q4 EPS (61c), consensus (50c) CGC Canopy Growth $5.89 / +0.3 (+5.37%) 04/07/22 Constellation Brands reports Q4 comparable EPS ex-Canopy losses $2.55 02/09/22 Canopy Growth reports Q3 EPS (C$0.28) vs. (C$2.43) a year ago ATAI Atai Life Sciences $4.07 / +0.125 (+3.17%) 05/16/22 Atai Life Sciences reports Q1 EPS (24c), consensus (24c) ACB Aurora Cannabis $3.08 / +0.175 (+6.02%) 05/12/22 Aurora Cannabis reports Q3 revenue C$50.43M vs. C$55.16M a year ago 02/10/22 Aurora Cannabis reports Q2 adjusted EBITDA (C$9M) vs. (C$11.5) in Q1 02/10/22 Aurora Cannabis reports Q2 revenue C$60.6M, vs. C$67.67M a year ago 01/04/22 Aurora Cannabis to deliver C$10M cannabis shipment to Israel 09 Dec 18 Jun GDNSF GDNSF Goodness Growth $1.42 / -0.05 (-3.40%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says GDNSF CRON CGC GDNSF Goodness Growth $1.42 / -0.05 (-3.40%) 05/19/22 Rising High: Exclusive talk with biotech company Tryp Therapeutics 05/12/22 Rising High: Exclusive talk with cannabis REIT NewLake Capital 05/05/22 Here's What You Missed in Cannabis, Psychedelics This Week 04/28/22 Here's What You Missed in Cannabis This Week CRON Cronos Group $3.48 / +0.155 (+4.66%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning CGC Canopy Growth $5.89 / +0.3 (+5.37%) 05/06/22 Proven algorithm says sell these stocks now 05/18/22 Global Farm to Market Conference 05/24/22 6th Annual Future of the Consumer: Sustainable Growth for a New Ecosystem 05/27/22 Canopy Growth - CGC 05/25/22 Relmada Therapeutics, Inc. 06/08/22 General Cannabis Corp. 06/14/22 Zynerba Pharmaceuticals, Inc. 06/16/22 COMPASS Pathways plc 06/16/22 Green Thumb Industries Inc. TLRY CRON CGC ATAI ACB TLRY Tilray $4.94 / +0.15 (+3.13%) 05/16/22 Tilray call volume above normal and directionally bullish 05/02/22 Put bomber drops one in Tilray 03/30/22 Tilray call volume above normal and directionally bullish 03/29/22 Largest borrow rate increases among liquid names CRON Cronos Group $3.48 / +0.155 (+4.66%) 03/25/22 Unusually active option classes on open March 25th CGC Canopy Growth $5.89 / +0.3 (+5.37%) 05/17/22 Largest borrow rate increases among liquid names 05/16/22 Canopy Growth call volume above normal and directionally bullish 05/06/22 Largest borrow rate increases among liquid names 05/03/22 Canopy Growth put volume heavy and directionally bearish ATAI Atai Life Sciences $4.07 / +0.125 (+3.17%) 12/21/21 Largest borrow rate increases among liquid names 12/16/21 Largest borrow rate increases among liquid names ACB Aurora Cannabis $3.08 / +0.175 (+6.02%) 05/12/22 Aurora Cannabis options imply 13.6% move in share price post-earnings 05/10/22 Unusually active option classes on open May 10th 03/28/22 Unusually active option classes on open March 28th

Wednesday
Hot Stocks	Aurora Cannabis receives EU-GMP certification for facility in Germany » 07:06 05/18/22 05/18 07:06 05/18/22 07:06 ACB Aurora Cannabis $3.09 / +0.155 (+5.28%) Aurora Cannabis announced… Aurora Cannabis announced the company has received EU-GMP certification for its state-of-the-art medical cannabis production facility in Germany. As a leading manufacturer of medical cannabis worldwide, achieving EU-GMP certification of the company's first German manufacturing site marks a significant milestone in the fulfillment of an awarded tender by the German Federal Institute for Drugs and Medical Devices. Aurora is the distinct market leader in the German flower segment and will now leverage receiving the world's highest quality standard to produce and distribute premium medical cannabis in Germany. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ACB Aurora Cannabis $3.09 / +0.155 (+5.28%) 05/12/22 Aurora Cannabis raises expense savings target to C$150M-C$170M 03/22/22 Aurora Cannabis to acquire Thrive Cannabis for $38M 02/10/22 Aurora Cannabis reaffirms goal of adjusted EBITDA profitability by 1H2023 02/03/22 Aurora Cannabis' Reliva launches new product line, KG7 ACB Aurora Cannabis $3.09 / +0.155 (+5.28%) 05/16/22 CIBC Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC 05/13/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald 04/01/22 Alliance Global Partners Senate remains the hurdle for MORE Act, says Alliance Global Partners 02/11/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald ACB Aurora Cannabis $3.09 / +0.155 (+5.28%) 05/12/22 Aurora Cannabis reports Q3 revenue C$50.43M vs. C$55.16M a year ago 02/10/22 Aurora Cannabis reports Q2 adjusted EBITDA (C$9M) vs. (C$11.5) in Q1 02/10/22 Aurora Cannabis reports Q2 revenue C$60.6M, vs. C$67.67M a year ago 01/04/22 Aurora Cannabis to deliver C$10M cannabis shipment to Israel ACB Aurora Cannabis $3.09 / +0.155 (+5.28%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says ACB Aurora Cannabis $3.09 / +0.155 (+5.28%) 05/12/22 Rising High: Exclusive talk with cannabis REIT NewLake Capital 05/05/22 Here's What You Missed in Cannabis, Psychedelics This Week 04/28/22 Here's What You Missed in Cannabis This Week 04/21/22 Rising High: Exclusive talk with psychedelics organization MAPS PBC ACB Aurora Cannabis $3.09 / +0.155 (+5.28%) 05/12/22 Aurora Cannabis options imply 13.6% move in share price post-earnings 05/10/22 Unusually active option classes on open May 10th 03/28/22 Unusually active option classes on open March 28th 03/25/22 Unusually active option classes on open March 25th

Monday
Recommendations	Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC » 12:35 05/16/22 05/16 12:35 05/16/22 12:35 ACB Aurora Cannabis $2.96 / +0.14 (+4.96%) CIBC analyst John Zamparo… CIBC analyst John Zamparo lowered the firm's price target on Aurora Cannabis to C$3.75 from C$6.50 and keeps a Neutral rating on the shares. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ACB Aurora Cannabis $2.96 / +0.14 (+4.96%) 05/12/22 Aurora Cannabis raises expense savings target to C$150M-C$170M 03/22/22 Aurora Cannabis to acquire Thrive Cannabis for $38M 02/10/22 Aurora Cannabis reaffirms goal of adjusted EBITDA profitability by 1H2023 02/03/22 Aurora Cannabis' Reliva launches new product line, KG7 ACB Aurora Cannabis $2.96 / +0.14 (+4.96%) 05/13/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald 04/01/22 Alliance Global Partners Senate remains the hurdle for MORE Act, says Alliance Global Partners 02/11/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald 02/03/22 CIBC Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC ACB Aurora Cannabis $2.96 / +0.14 (+4.96%) 05/12/22 Aurora Cannabis reports Q3 revenue C$50.43M vs. C$55.16M a year ago 02/10/22 Aurora Cannabis reports Q2 adjusted EBITDA (C$9M) vs. (C$11.5) in Q1 02/10/22 Aurora Cannabis reports Q2 revenue C$60.6M, vs. C$67.67M a year ago 01/04/22 Aurora Cannabis to deliver C$10M cannabis shipment to Israel ACB Aurora Cannabis $2.96 / +0.14 (+4.96%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says ACB Aurora Cannabis $2.96 / +0.14 (+4.96%) 05/12/22 Rising High: Exclusive talk with cannabis REIT NewLake Capital 05/05/22 Here's What You Missed in Cannabis, Psychedelics This Week 04/28/22 Here's What You Missed in Cannabis This Week 04/21/22 Rising High: Exclusive talk with psychedelics organization MAPS PBC ACB Aurora Cannabis $2.96 / +0.14 (+4.96%) 05/12/22 Aurora Cannabis options imply 13.6% move in share price post-earnings 05/10/22 Unusually active option classes on open May 10th 03/28/22 Unusually active option classes on open March 28th 03/25/22 Unusually active option classes on open March 25th

Over a week ago
Recommendations	Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald » 07:55 05/13/22 05/13 07:55 05/13/22 07:55 ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) Cantor Fitzgerald analyst… Cantor Fitzgerald analyst Pablo Zuanic lowered the firm's price target on Aurora Cannabis to C$3.90 from C$7.60 and keeps a Neutral rating on the shares. Aurora Cannabis increased cash cost savings targets which gives further credence to its goal of becoming EBITDA positive by this coming December on a run rate basis, Zuanic tells investors in a research note. Question marks remain about the lack of profitability and cash flows, Zuanic adds. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 05/12/22 Aurora Cannabis raises expense savings target to C$150M-C$170M 03/22/22 Aurora Cannabis to acquire Thrive Cannabis for $38M 02/10/22 Aurora Cannabis reaffirms goal of adjusted EBITDA profitability by 1H2023 02/03/22 Aurora Cannabis' Reliva launches new product line, KG7 ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 04/01/22 Alliance Global Partners Senate remains the hurdle for MORE Act, says Alliance Global Partners 02/11/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald 02/03/22 CIBC Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC 11/11/21 Canaccord Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 05/12/22 Aurora Cannabis reports Q3 revenue C$50.43M vs. C$55.16M a year ago 02/10/22 Aurora Cannabis reports Q2 adjusted EBITDA (C$9M) vs. (C$11.5) in Q1 02/10/22 Aurora Cannabis reports Q2 revenue C$60.6M, vs. C$67.67M a year ago 01/04/22 Aurora Cannabis to deliver C$10M cannabis shipment to Israel ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says 11/15/21 Republicans introduce cannabis legalization bill, Insider says ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 05/12/22 Rising High: Exclusive talk with cannabis REIT NewLake Capital 05/05/22 Here's What You Missed in Cannabis, Psychedelics This Week 04/28/22 Here's What You Missed in Cannabis This Week 04/21/22 Rising High: Exclusive talk with psychedelics organization MAPS PBC ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 05/12/22 Aurora Cannabis options imply 13.6% move in share price post-earnings 05/10/22 Unusually active option classes on open May 10th 03/28/22 Unusually active option classes on open March 28th 03/25/22 Unusually active option classes on open March 25th
Hot Stocks	Aurora Cannabis raises expense savings target to C$150M-C$170M » 16:20 05/12/22 05/12 16:20 05/12/22 16:20 ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) Now expects C$150M-C$170M… Now expects C$150M-C$170M in Annualized cost savings by H1/2023 versus stated target of C$60M-C$80M. "We continue to steer our differentiated global cannabis business towards long term shareholder value creation. This is being accomplished through a sole focus on the most profitable growth opportunities, rationalization of our Canadian cost structure and disciplined use of capital. Our plan is working and we remain firmly on track to achieving a positive Adjusted EBITDA run rate by the first half of fiscal 2023. Today, we are announcing further cost savings which will enable us to increase our range of savings under our business transformation plan from $60 to $80 million to $150 to $170 million. Our balance sheet also remains among the strongest in the industry, enabling the repurchase of $141.4 million in convertible debt early, while also providing meaningful working capital to support organic growth and pursue strategic M&A, such as our recent acquisition of Thrive Cannabis," stated Miguel Martin, CEO of Aurora. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 03/22/22 Aurora Cannabis to acquire Thrive Cannabis for $38M 02/10/22 Aurora Cannabis reaffirms goal of adjusted EBITDA profitability by 1H2023 02/03/22 Aurora Cannabis' Reliva launches new product line, KG7 12/14/21 Aurora Cannabis and 22nd Century sign license agreement with Cronos Group ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 04/01/22 Alliance Global Partners Senate remains the hurdle for MORE Act, says Alliance Global Partners 02/11/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald 02/03/22 CIBC Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC 11/11/21 Canaccord Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 05/12/22 Aurora Cannabis reports Q3 revenue C$50.43M vs. C$55.16M a year ago 02/10/22 Aurora Cannabis reports Q2 adjusted EBITDA (C$9M) vs. (C$11.5) in Q1 02/10/22 Aurora Cannabis reports Q2 revenue C$60.6M, vs. C$67.67M a year ago 01/04/22 Aurora Cannabis to deliver C$10M cannabis shipment to Israel ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says 11/15/21 Republicans introduce cannabis legalization bill, Insider says ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 05/12/22 Rising High: Exclusive talk with cannabis REIT NewLake Capital 05/05/22 Here's What You Missed in Cannabis, Psychedelics This Week 04/28/22 Here's What You Missed in Cannabis This Week 04/21/22 Rising High: Exclusive talk with psychedelics organization MAPS PBC 05/12/22 Aurora Cannabis - ACB ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 05/12/22 Aurora Cannabis options imply 13.6% move in share price post-earnings 05/10/22 Unusually active option classes on open May 10th 03/28/22 Unusually active option classes on open March 28th 03/25/22 Unusually active option classes on open March 25th

Earnings	Aurora Cannabis reports Q3 revenue C$50.43M vs. C$55.16M a year ago » 16:18 05/12/22 05/12 16:18 05/12/22 16:18 ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) Adjusted gross margin… Adjusted gross margin before fair value adjustments on cannabis net revenue was 54% in Q3 2022 versus 53% in the prior quarter and 44% in Q3 2021. The increase in adjusted gross margin compared to the prior year period is due to increased sales in our international medical markets which command significantly higher average net selling prices and margins. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 03/22/22 Aurora Cannabis to acquire Thrive Cannabis for $38M 02/10/22 Aurora Cannabis reaffirms goal of adjusted EBITDA profitability by 1H2023 02/03/22 Aurora Cannabis' Reliva launches new product line, KG7 12/14/21 Aurora Cannabis and 22nd Century sign license agreement with Cronos Group ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 04/01/22 Alliance Global Partners Senate remains the hurdle for MORE Act, says Alliance Global Partners 02/11/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald 02/03/22 CIBC Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC 11/11/21 Canaccord Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 02/10/22 Aurora Cannabis reports Q2 adjusted EBITDA (C$9M) vs. (C$11.5) in Q1 02/10/22 Aurora Cannabis reports Q2 revenue C$60.6M, vs. C$67.67M a year ago 01/04/22 Aurora Cannabis to deliver C$10M cannabis shipment to Israel ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says 11/15/21 Republicans introduce cannabis legalization bill, Insider says ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 05/12/22 Rising High: Exclusive talk with cannabis REIT NewLake Capital 05/05/22 Here's What You Missed in Cannabis, Psychedelics This Week 04/28/22 Here's What You Missed in Cannabis This Week 04/21/22 Rising High: Exclusive talk with psychedelics organization MAPS PBC 05/12/22 Aurora Cannabis - ACB ACB Aurora Cannabis $2.42 / +0.125 (+5.46%) 05/12/22 Aurora Cannabis options imply 13.6% move in share price post-earnings 05/10/22 Unusually active option classes on open May 10th 03/28/22 Unusually active option classes on open March 28th 03/25/22 Unusually active option classes on open March 25th
Options	Aurora Cannabis options imply 13.6% move in share price post-earnings » 14:04 05/12/22 05/12 14:04 05/12/22 14:04 ACB Aurora Cannabis $2.34 / +0.05 (+2.18%) Pre-earnings options… Pre-earnings options volume in Aurora Cannabis is 2.3x normal with calls leading puts 7:4. Implied volatility suggests the market is anticipating a move near 13.6%, or 32c, after results are released. Median move over the past eight quarters is 10.2%. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ACB Aurora Cannabis $2.34 / +0.05 (+2.18%) 03/22/22 Aurora Cannabis to acquire Thrive Cannabis for $38M 02/10/22 Aurora Cannabis reaffirms goal of adjusted EBITDA profitability by 1H2023 02/03/22 Aurora Cannabis' Reliva launches new product line, KG7 12/14/21 Aurora Cannabis and 22nd Century sign license agreement with Cronos Group ACB Aurora Cannabis $2.34 / +0.05 (+2.18%) 04/01/22 Alliance Global Partners Senate remains the hurdle for MORE Act, says Alliance Global Partners 02/11/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald 02/03/22 CIBC Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC 11/11/21 Canaccord Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord ACB Aurora Cannabis $2.34 / +0.05 (+2.18%) 02/10/22 Aurora Cannabis reports Q2 adjusted EBITDA (C$9M) vs. (C$11.5) in Q1 02/10/22 Aurora Cannabis reports Q2 revenue C$60.6M, vs. C$67.67M a year ago 01/04/22 Aurora Cannabis to deliver C$10M cannabis shipment to Israel ACB Aurora Cannabis $2.34 / +0.05 (+2.18%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says 11/15/21 Republicans introduce cannabis legalization bill, Insider says ACB Aurora Cannabis $2.34 / +0.05 (+2.18%) 05/12/22 Rising High: Exclusive talk with cannabis REIT NewLake Capital 05/05/22 Here's What You Missed in Cannabis, Psychedelics This Week 04/28/22 Here's What You Missed in Cannabis This Week 04/21/22 Rising High: Exclusive talk with psychedelics organization MAPS PBC 05/12/22 Aurora Cannabis - ACB ACB Aurora Cannabis $2.34 / +0.05 (+2.18%) 05/10/22 Unusually active option classes on open May 10th 03/28/22 Unusually active option classes on open March 28th 03/25/22 Unusually active option classes on open March 25th 03/23/22 Unusually active option classes on open March 23rd
On The Fly	Rising High: Exclusive talk with cannabis REIT NewLake Capital » 11:42 05/12/22 05/12 11:42 05/12/22 11:42 RLMD Relmada Therapeutics $18.51 / -0.07 (-0.38%) , CMPS Compass Pathways $7.03 / +0.23 (+3.38%) , ATAI Atai Life Sciences $3.32 / +0.19 (+6.07%) , ZYNE Zynerba / + , TCNNF Trulieve Cannabis $13.60 / -0.43 (-3.06%) , TLRY Tilray $4.43 / +0.37 (+9.11%) , IGC India Globalization Capital / + , GTBIF Green Thumb Industries $11.76 / +0.05 (+0.43%) , GDNSF Goodness Growth $1.49 / -0.032 (-2.11%) , CANN General Cannabis / + , CRON Cronos Group $3.14 / +0.15 (+5.02%) , CGC Canopy Growth $5.47 / +0.49 (+9.84%) , CTST CannTrust / + , CVSI CV Sciences / + , ACB Aurora Cannabis $2.47 / +0.175 (+7.64%) , NLCP NewLake Capital Partners $19.88 / +0.03 (+0.15%) In this edition of… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZYNE TLRY TCNNF RLMD NLCP IGC GTBIF GDNSF CVSI CTST CRON CMPS CGC ATAI ACB ZYNE Zynerba / + 05/11/22 Zynerba presents long-term safety, efficacy data of Zygel 05/02/22 Zynerba presents long-term safety, efficacy data of Zygel 04/18/22 Tela Bio appoints D. Taylor Ocasio as general counsel 02/28/22 Zynerba announces EC grants orphan drug designation for Zygel TLRY Tilray $4.43 / +0.37 (+9.11%) 05/12/22 Tilray announces expansion of Good Supply's cannabis portfolio 04/12/22 HEXO, Tilray enter agreement for strategic alliance 04/12/22 Tilray enters agreement with HEXO related to Senior Secured Convertible Note 04/06/22 Tilray subsidiary Manitoba Harvest partners with Whole Foods Market TCNNF Trulieve Cannabis $13.60 / -0.43 (-3.06%) 03/22/22 Tilt appoints Lynn Ricci as VP, investor relations, corporate communications 12/28/21 Trulieve appoints Steve White as president, Nicole Stanton as general counsel 12/28/21 Trulieve Cannabis acquires PurpleMed Healting Center in Arizona 11/29/21 Trulieve Cannabis issues first inaugural ESG report RLMD Relmada Therapeutics $18.51 / -0.07 (-0.38%) 04/29/22 Relmada Therapeutics announces publication of REL-1017 preclinical study 02/23/22 Relmada Therapeutics announces results from REL-1017 HAP study 12/22/21 Relmada Therapeutics: REL-1017 Phase 2 results published in AJOP NLCP NewLake Capital Partners $19.88 / +0.03 (+0.15%) 05/09/22 NewLake Capital Partners enters revolving credit facility 04/06/22 NewLake Capital Partners acquires cultivation property in Missouri for $34M 12/21/21 NewLake Capital Partners acquires Missouri property for $21.1M investment 12/16/21 NewLake Capital Partners raises quarterly dividend 29% to 31c per share IGC India Globalization Capital / + 12/08/21 India Globalization Capital says IGC-AD1 ph 1 trial provided 'valuable insight' 12/02/21 India Globalization Capital presents findings from Phase 1 trial of IGC-AD1 GTBIF Green Thumb Industries $11.76 / +0.05 (+0.43%) 05/02/22 Green Thumb announces internet availability of proxy materials for 2022 meeting 04/11/22 Green Thumb Industries to open RISE Mankato on April 14 03/11/22 Green Thumb Industries announces departure of Moore from board of directors 02/08/22 Green Thumb Industries appoints Dorri McWhorter to board of directors GDNSF Goodness Growth $1.49 / -0.032 (-2.11%) 02/28/22 Goodness Growth launches full line of cannabis flower in Minnesota 02/01/22 Verano Holdings to acquire Goodness Growth in $413M all-share transaction CVSI CV Sciences / + 03/08/22 CV Sciences adds +PlusCBD Relief Softgels to its Wellness line 01/11/22 CV Sciences launches +PlusCBD Pain Relief topicals 01/05/22 CV Sciences announces new distribution agreement with GNC 11/15/21 CV Sciences announces convertible note financing CTST CannTrust / + 01/06/22 CannTrust reports implementation of CCAA plan, settlement of lawsuits CRON Cronos Group $3.14 / +0.15 (+5.02%) 03/21/22 Cronos Group founder Mike Gorenstein returns as CEO 03/01/22 Cronos Group announces planned exit of Peace Naturals Campus in Ontario 02/18/22 Cronos Group announces strategic realignment for $20M-$25M in savings 02/18/22 Cronos Group completes Audit Committee evaluation CMPS Compass Pathways $7.03 / +0.23 (+3.38%) 05/09/22 Compass Pathways to fund study of COMP360 psilocybin in autistic adults 05/03/22 Compass Pathways announces data on COMP360 psilocybin therapy 04/20/22 Compass Pathways partners with One Mind for Rising Star Awards 03/24/22 Compass Pathways, partners to launch psychedelic research facility CGC Canopy Growth $5.47 / +0.49 (+9.84%) 04/26/22 Canopy Growth expects to generate savings of $100M-$150M within 12-18 months 04/26/22 Canopy Growth announces cost reduction initiatives including headcount reduction 03/31/22 Canopy Growth appoints Judy Hong as CFO, Jonathan Di Tosto as COO 03/22/22 Canopy Growth announces results from trial using CBD on menstrual symptoms ATAI Atai Life Sciences $3.32 / +0.19 (+6.07%) 03/30/22 Atai Life Sciences reports Q4 net loss $88.9M vs. $86.6M a year ago 02/01/22 IntelGenx receives third loan tranche from Atai Life Sciences 01/27/22 Atai Life Sciences to partner with Dalriada 01/12/22 atai Life Sciences' IND for PCN-101 approved by FDA ACB Aurora Cannabis $2.47 / +0.175 (+7.64%) 03/22/22 Aurora Cannabis to acquire Thrive Cannabis for $38M 02/10/22 Aurora Cannabis reaffirms goal of adjusted EBITDA profitability by 1H2023 02/03/22 Aurora Cannabis' Reliva launches new product line, KG7 12/14/21 Aurora Cannabis and 22nd Century sign license agreement with Cronos Group RLMD CMPS ATAI ZYNE TCNNF TLRY IGC GTBIF GDNSF CANN CRON CGC CTST CVSI ACB NLCP RLMD Relmada Therapeutics $18.51 / -0.07 (-0.38%) 05/09/22 Oppenheimer Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer 12/20/21 SVB Leerink Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink 11/17/21 Mizuho Relmada Therapeutics initiated with a Buy at Mizuho 09/30/21 Jefferies Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study CMPS Compass Pathways $7.03 / +0.23 (+3.38%) 02/28/22 Canaccord Compass Pathways price target lowered to $78 from $80 at Canaccord 11/11/21 Roth Capital Atai Life Sciences initiated with a Buy at Roth Capital 11/09/21 Citi Citi says Compass Pathways selloff overdone, ups price target to $70 11/09/21 Cantor Fitzgerald Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald ATAI Atai Life Sciences $3.32 / +0.19 (+6.07%) 04/01/22 Canaccord Atai Life Sciences price target lowered to $27 from $28 at Canaccord 03/31/22 RBC Capital Atai Life Sciences price target lowered to $9 from $12 at RBC Capital 11/30/21 Fly Intel: Top five analyst initiations 11/30/21 Maxim Atai Life Sciences initiated with a Buy at Maxim ZYNE Zynerba / + 04/01/22 Alliance Global Partners Senate remains the hurdle for MORE Act, says Alliance Global Partners 06/25/21 Alliance Global Partners Cannabis selloff brings buying opportunities, says Alliance Global TCNNF Trulieve Cannabis $13.60 / -0.43 (-3.06%) 05/12/22 Alliance Global Partners Trulieve Cannabis price target lowered to C$50 from C$60 at Alliance Global Partners 03/31/22 Canaccord Trulieve Cannabis price target lowered to C$65 from C$70 at Canaccord 03/30/22 Alliance Global Partners Trulieve Cannabis price target lowered to C$60 from C$76 at Alliance Global Partners TLRY Tilray $4.43 / +0.37 (+9.11%) 05/02/22 Alliance Global Partners Tilray price target lowered to $5.50 from $8 at Alliance Global Partners 04/20/22 Barclays Tilray price target lowered to $4.50 from $8.50 at Barclays 04/06/22 MKM Partners Tilray margins contracted despite cost savings, says MKM Partners 04/06/22 Benchmark Tilray fiscal Q3 results 'disappointing,' says Benchmark IGC India Globalization Capital / + GTBIF Green Thumb Industries $11.76 / +0.05 (+0.43%) 05/05/22 Alliance Global Partners Green Thumb price target lowered to C$38 from C$40 at Alliance Global 05/05/22 Craig-Hallum Green Thumb Industries price target lowered to $25 from $35 at Craig-Hallum 05/05/22 Needham Green Thumb Industries price target lowered to $26 from $33 at Needham GDNSF Goodness Growth $1.49 / -0.032 (-2.11%) 05/12/22 Canaccord Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord 02/01/22 Craig-Hallum Goodness Growth downgraded to Hold from Buy at Craig-Hallum 11/11/21 Canaccord Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord CANN General Cannabis / + CRON Cronos Group $3.14 / +0.15 (+5.02%) 05/11/22 CIBC CIBC upgrades Cronos to buy on 'multiple reasons for optimism' 05/11/22 Canaccord Cronos upgraded to Hold on operational improvements at Canaccord 05/11/22 CIBC Cronos Group upgraded to Outperformer from Neutral at CIBC 05/11/22 Canaccord Cronos Group upgraded to Hold from Sell at Canaccord CGC Canopy Growth $5.47 / +0.49 (+9.84%) 04/04/22 Morgan Stanley Constellation Brands price target lowered to $294 from $299 at Morgan Stanley 03/22/22 Barclays Canopy Growth downgraded to Underweight from Equal Weight at Barclays 03/01/22 Barclays Canopy Growth price target lowered to $9 from $14 at Barclays CTST CannTrust / + CVSI CV Sciences / + ACB Aurora Cannabis $2.47 / +0.175 (+7.64%) 05/13/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald 02/11/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald 02/03/22 CIBC Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC NLCP NewLake Capital Partners $19.88 / +0.03 (+0.15%) 03/21/22 Ladenburg NewLake Capital price target lowered to $39.50 from $44 at Ladenburg 09/08/21 Compass Point NewLake Capital Partners initiated with a Buy at Compass Point 09/07/21 Ladenburg NewLake Capital Partners initiated with a Buy at Ladenburg ZYNE TLRY TCNNF RLMD NLCP GTBIF CVSI CRON CMPS CGC ATAI ACB ZYNE Zynerba / + 03/01/22 Zynerba reports Q4 EPS (22c), consensus (26c) 11/15/21 Zynerba reports Q3 EPS (26c), consensus (25c) TLRY Tilray $4.43 / +0.37 (+9.11%) 04/06/22 Tilray reports Q3 EPS 9c vs. ($1.03) last year 01/10/22 Tilray reports Q2 revenue $155M vs. $129M last year TCNNF Trulieve Cannabis $13.60 / -0.43 (-3.06%) 05/12/22 Trulieve Cannabis reiterates 2022 revenue view $1.3B-$1.4B 05/12/22 Trulieve Cannabis reports Q1 adjusted EPS 1c vs. 30c last year RLMD Relmada Therapeutics $18.51 / -0.07 (-0.38%) 05/05/22 Relmada Therapeutics reports Q1 EPS ($1.40), consensus ($1.27) 03/23/22 Relmada Therapeutics reports Q4 EPS ($1.80), consensus ($1.83) NLCP NewLake Capital Partners $19.88 / +0.03 (+0.15%) 03/17/22 NewLake Capital Partners reports Q4 adjusted FFO 32c vs. 63c last year GTBIF Green Thumb Industries $11.76 / +0.05 (+0.43%) 03/01/22 Green Thumb Industries reports Q4 EPS 10c vs. 11c last year CVSI CV Sciences / + 11/15/21 CV Sciences reports Q3 EPS 0c vs. (3c) last year CRON Cronos Group $3.14 / +0.15 (+5.02%) 05/10/22 Cronos Group reports Q1 EPS (9c), consensus (8c) 03/01/22 Cronos Group reports 2021 EPS ($1.07), consensus (47c) 02/18/22 Cronos Group reports Q3 EPS 21c, consensus (10c) CMPS Compass Pathways $7.03 / +0.23 (+3.38%) 05/10/22 Compass Pathways reports Q1 EPS (50c), consensus (67c) 02/24/22 Compass Pathways reports Q4 EPS (61c), consensus (50c) CGC Canopy Growth $5.47 / +0.49 (+9.84%) 04/07/22 Constellation Brands reports Q4 comparable EPS ex-Canopy losses $2.55 02/09/22 Canopy Growth reports Q3 EPS (C$0.28) vs. (C$2.43) a year ago ATAI Atai Life Sciences $3.32 / +0.19 (+6.07%) 11/15/21 Atai Life Sciences reports Q3 EPS (21c), consensus (20c) ACB Aurora Cannabis $2.47 / +0.175 (+7.64%) 02/10/22 Aurora Cannabis reports Q2 adjusted EBITDA (C$9M) vs. (C$11.5) in Q1 02/10/22 Aurora Cannabis reports Q2 revenue C$60.6M, vs. C$67.67M a year ago 01/04/22 Aurora Cannabis to deliver C$10M cannabis shipment to Israel 09 Dec 18 Jun ZYNE ZYNE Zynerba / + 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says 11/15/21 Republicans introduce cannabis legalization bill, Insider says RLMD NLCP CRON CGC RLMD Relmada Therapeutics $18.51 / -0.07 (-0.38%) 05/12/22 Rising High: Exclusive talk with cannabis REIT NewLake Capital 05/05/22 Here's What You Missed in Cannabis, Psychedelics This Week 04/28/22 Here's What You Missed in Cannabis This Week 04/21/22 Rising High: Exclusive talk with psychedelics organization MAPS PBC NLCP NewLake Capital Partners $19.88 / +0.03 (+0.15%) 01/27/22 Rising High: Exclusive talk with cannabis REIT NewLake Capital CRON Cronos Group $3.14 / +0.15 (+5.02%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning CGC Canopy Growth $5.47 / +0.49 (+9.84%) 05/06/22 Proven algorithm says sell these stocks now 05/24/22 6th Annual Future of the Consumer: Sustainable Growth for a New Ecosystem 05/12/22 NewLake Capital Partners - NLCP 05/12/22 Aurora Cannabis - ACB 05/16/22 Atai Life Sciences - ATAI 05/25/22 Relmada Therapeutics, Inc. 06/07/22 NewLake Capital Partners 06/08/22 General Cannabis Corp. 06/14/22 Zynerba Pharmaceuticals, Inc. 06/16/22 COMPASS Pathways plc 06/16/22 Green Thumb Industries Inc. TLRY CRON CGC ATAI ACB TLRY Tilray $4.43 / +0.37 (+9.11%) 05/02/22 Put bomber drops one in Tilray 03/30/22 Tilray call volume above normal and directionally bullish 03/29/22 Largest borrow rate increases among liquid names 03/28/22 Unusually active option classes on open March 28th CRON Cronos Group $3.14 / +0.15 (+5.02%) 03/25/22 Unusually active option classes on open March 25th 11/12/21 Cronos Group call volume above normal and directionally bullish CGC Canopy Growth $5.47 / +0.49 (+9.84%) 05/06/22 Largest borrow rate increases among liquid names 05/03/22 Canopy Growth put volume heavy and directionally bearish 04/29/22 Largest borrow rate increases among liquid names 04/25/22 Largest borrow rate increases among liquid names ATAI Atai Life Sciences $3.32 / +0.19 (+6.07%) 12/21/21 Largest borrow rate increases among liquid names 12/16/21 Largest borrow rate increases among liquid names ACB Aurora Cannabis $2.47 / +0.175 (+7.64%) 05/10/22 Unusually active option classes on open May 10th 03/23/22 Unusually active option classes on open March 23rd
Options	Unusually active option classes on open May 10th » 09:40 05/10/22 05/10 09:40 05/10/22 09:40 VTNR Vertex Energy $9.49 / + (+0.00%) , ACB Aurora Cannabis $2.53 / + (+0.00%) , NOK Nokia $4.78 / + (+0.00%) , FCEL FuelCell $3.50 / +0.005 (+0.14%) , TBT ProShares UltraShort 20+ yr Trsry $26.76 / +0.005 (+0.02%) , RIVN Rivian Automotive $22.60 / + (+0.00%) , LI Li Auto $18.91 / + (+0.00%) , XLK Technology Select Sector SPDR $135.27 / + (+0.00%) , MO Altria Group $55.26 / + (+0.00%) , EMB iShares JP Morgan USD Emerging Markets Bond ETF $88.55 / + (+0.00%) Unusual total active… Unusual total active option classes on open include: Vertex Energy (VTNR), Aurora Cannabis (ACB), Nokia (NOK), FuelCell (FCEL), ProShares UltraShort Lehman 20 plus Year Treasury (TBT), Rivian (RIVN), Li Auto (LI), Technology Sector SPDR ETF (XLK), Altria Group (MO), and iShares Emerging Markets Bond ETF (EMB). ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options Technical Analysis VTNR RIVN NOK MO LI FCEL ACB VTNR Vertex Energy $9.49 / + (+0.00%) 04/01/22 Vertex Energy completes acquisition of Mobile refinery from Shell 02/17/22 Vertex Energy announces five-year renewable diesel supply agreement RIVN Rivian Automotive $22.60 / + (+0.00%) 05/08/22 Fly Intel: Top five weekend stock stories 05/03/22 Rivian to receive $1.5B incentives package to build EV factory in Georgia 04/28/22 Rivian Automotive, Clearloop partner on renewable electricity 04/14/22 Rivian Automotive appoints Anisa Kamadoli Costa as chief sustainability officer NOK Nokia $4.78 / + (+0.00%) 05/09/22 Nokia launches cybersecurity-focused testing lab in US 05/06/22 Nokia chief people officer Stephanie Werner-Dietz to step down 04/12/22 Nokia to exit Russian market, sees EUR 100M provision in Q1 03/29/22 Nokia selected by Chunghwa Telecom to enhance 5G network across Taiwan MO Altria Group $55.26 / + (+0.00%) 04/28/22 FDA proposes rules prohibiting menthol cigarettes and flavored cigars 04/13/22 JUUL to pay Washington $22.5M over advertising practices 04/11/22 Lexaria Bioscience enters new agreements with Altria Client Services 03/11/22 FDA authorizes reduced exposure claim for IQOS 3 System Holder and Charger LI Li Auto $18.91 / + (+0.00%) 05/01/22 Li Auto delivers 4,167 Li ONEs in April 2022 04/22/22 Li Auto updates status under HFCAA 04/21/22 Li Auto, KE Holdings among new additions to SEC HFCAA provisional list 04/01/22 Li Auto delivers 11,034 Li Ones in March and 31,716 in Q1 FCEL FuelCell $3.50 / +0.005 (+0.14%) 05/05/22 FuelCell extends term of agreement with ExxonMobil 04/06/22 FuelCell appoints Feasel as EVP, CCO 02/17/22 FuelCell says carbon capture demonstration project awarded $6.8M by CRIN 02/02/22 FuelCell releases first sustainability report ACB Aurora Cannabis $2.53 / + (+0.00%) 03/22/22 Aurora Cannabis to acquire Thrive Cannabis for $38M 02/10/22 Aurora Cannabis reaffirms goal of adjusted EBITDA profitability by 1H2023 02/03/22 Aurora Cannabis' Reliva launches new product line, KG7 12/14/21 Aurora Cannabis and 22nd Century sign license agreement with Cronos Group VTNR ACB NOK FCEL TBT RIVN LI XLK MO EMB VTNR Vertex Energy $9.49 / + (+0.00%) 12/01/21 Credit Suisse Vertex Energy initiated with an Outperform at Credit Suisse 11/09/21 Craig-Hallum Vertex Energy price target lowered to $18 from $25 at Craig-Hallum 06/30/21 Craig-Hallum Vertex Energy price target raised to $25 from $13 at Craig-Hallum 06/01/21 Stifel Vertex Energy price target raised to $17 from $2 at Stifel ACB Aurora Cannabis $2.53 / + (+0.00%) 04/01/22 Alliance Global Partners Senate remains the hurdle for MORE Act, says Alliance Global Partners 02/11/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald 02/03/22 CIBC Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC 11/11/21 Canaccord Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord NOK Nokia $4.78 / + (+0.00%) 04/29/22 UBS Nokia price target lowered to EUR 5.80 from EUR 6.20 at UBS 04/29/22 Societe Generale Nokia price target lowered to EUR 6.10 from EUR 6.70 at Societe Generale 03/17/22 Jefferies Nokia initiated with a Buy at Jefferies 03/14/22 Raymond James Raymond James upgrades Nokia to Outperform on improved position FCEL FuelCell $3.50 / +0.005 (+0.14%) 04/26/22 KeyBanc KeyBanc says Axios report positive for Plug Power, other fuel cell names 02/08/22 B. Riley FuelCell price target lowered to $5 from $6 at B. Riley 01/20/22 JPMorgan FuelCell price target lowered to $5 from $7 at JPMorgan 01/05/22 KeyBanc FuelCell initiated with a Sector Weight at KeyBanc TBT ProShares UltraShort 20+ yr Trsry $26.76 / +0.005 (+0.02%) RIVN Rivian Automotive $22.60 / + (+0.00%) 05/02/22 Piper Sandler Piper Sandler favors Rivian for exposure to commercial vans 05/02/22 Benchmark Ford price target lowered to $25 from $29 at Benchmark 04/26/22 Barclays Rivian Automotive price target lowered to $38 from $42 at Barclays 04/25/22 JPMorgan Ford price target lowered to $21 from $22 at JPMorgan LI Li Auto $18.91 / + (+0.00%) 04/04/22 UBS Li Auto price target raised to $52 from $47 at UBS 04/01/22 HSBC Li Auto initiated with a Buy at HSBC 03/24/22 China Renaissance China Renaissance starts 'bellwether' Li Auto with Buy, $37.20 target 03/23/22 China Renaissance Li Auto initiated with a Buy at China Renaissance XLK Technology Select Sector SPDR $135.27 / + (+0.00%) MO Altria Group $55.26 / + (+0.00%) 05/10/22 Bernstein Altria Group downgraded to Market Perform from Outperform at Bernstein 05/09/22 Jefferies PM buying Swedish Match would have negative read for Altria, says Jefferies 04/29/22 Deutsche Bank Altria Group price target raised to $60 from $54 at Deutsche Bank 04/07/22 Cowen Altria Group price target raised to $53 from $51 at Cowen EMB iShares JP Morgan USD Emerging Markets Bond ETF $88.55 / + (+0.00%) VTNR RIVN NOK MO LI FCEL ACB VTNR Vertex Energy $9.49 / + (+0.00%) 05/10/22 Vertex Energy sees FY23 adjusted EBITDA $425M-$450M 05/10/22 Vertex Energy sees FY22 adjusted EBITDA $340M-$360M 05/10/22 Vertex Energy reports Q1 EPS (8c), consensus (14c) 03/08/22 Vertex Energy reports 2021 EPS (36c), consensus (21c) RIVN Rivian Automotive $22.60 / + (+0.00%) 04/28/22 Amazon reports Q1 EPS ($7.56) with Rivian expense, consensus $8.36 03/10/22 Rivian sees FY22 adjusted EBITDA ($4.75B) 03/10/22 Rivian reports Q4 EPS ($4.83) vs ($1.97) 03/10/22 Notable companies reporting after market close NOK Nokia $4.78 / + (+0.00%) 04/28/22 Nokia raises FY22 revenue view to EUR 22.9B-EUR 24.1B from EUR 22.6B-EUR 23.8B 04/28/22 Nokia reports Q1 comparable EPS EUR 0.07 vs EUR 0.07 last year 02/03/22 Nokia sees FY22 revenue EUR 22.6B-EUR 23.8B 02/03/22 Nokia reports Q4 comparable EPS EUR0.13 vs. EUR 0.14 last year MO Altria Group $55.26 / + (+0.00%) 04/28/22 Altria Group backs FY22 adjusted EPS $4.79-$4.93, consensus $4.84 04/28/22 Altria Group reports Q1 adjusted EPS $1.12, consensus $1.18 04/27/22 Notable companies reporting before tomorrow's open LI Li Auto $18.91 / + (+0.00%) 02/25/22 Li Auto sees Q1 revenue $1.39B-$1.48B, one estimate $1.58B 02/25/22 Li Auto reports Q4 EPS 2c, consensus (4c) 02/24/22 Notable companies reporting before tomorrow's open FCEL FuelCell $3.50 / +0.005 (+0.14%) 03/10/22 FuelCell reports Q4 EPS (11c), consensus (5c) 12/29/21 FuelCell reports Q4 EPS (7c), consensus (4c) ACB Aurora Cannabis $2.53 / + (+0.00%) 02/10/22 Aurora Cannabis reports Q2 adjusted EBITDA (C$9M) vs. (C$11.5) in Q1 02/10/22 Aurora Cannabis reports Q2 revenue C$60.6M, vs. C$67.67M a year ago 01/04/22 Aurora Cannabis to deliver C$10M cannabis shipment to Israel 10 Nov 13 Aug RIVN NOK MO LI ACB RIVN Rivian Automotive $22.60 / + (+0.00%) 05/09/22 Third largest Rivian holder tells Bloomberg 'no plans' to cut stake 05/08/22 Ford to sell 8M shares of Rivian with lockup expiring, CNBC reports 04/18/22 Rivian CEO: EV battery shortage could be worse than chip shortage, WSJ reports 03/01/22 Rivian Auto says delivery of dual-motor R1S and R1T to start in 2024, CNET says NOK Nokia $4.78 / + (+0.00%) 02/19/22 Might be the time to plug into Nokia's stock, Barron's says MO Altria Group $55.26 / + (+0.00%) 12/07/21 Philip Morris seeking emergency order to continue IQOS U.S. sales, Bloomberg says 12/07/21 Philip Morris seeks emergency order to keep selling IQOS in U.S., Bloomberg says LI Li Auto $18.91 / + (+0.00%) 02/06/22 Rising battery prices add uncertainty to EV costs, WSJ reports 11/27/21 Nio, Xpeng, Li Auto look set to grow on bigger sales, Barron's says ACB Aurora Cannabis $2.53 / + (+0.00%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says 11/15/21 Republicans introduce cannabis legalization bill, Insider says VTNR RIVN NOK MO LI FCEL ACB VTNR Vertex Energy $9.49 / + (+0.00%) 03/08/22 What You Missed On Wall Street On Tuesday 03/08/22 What You Missed On Wall Street This Morning 02/22/22 Fly Intel: After-Hours Movers RIVN Rivian Automotive $22.60 / + (+0.00%) 05/09/22 What You Missed On Wall Street This Morning 05/09/22 What You Missed This Week in EVs and Clean Energy 05/09/22 Fly Intel: Pre-market Movers 05/04/22 Here's what Wall Street experts are saying about these EV names ahead of results NOK Nokia $4.78 / + (+0.00%) 04/12/22 What You Missed On Wall Street On Tuesday 04/12/22 What You Missed On Wall Street This Morning 03/14/22 What You Missed On Wall Street On Monday 03/14/22 What You Missed On Wall Street This Morning MO Altria Group $55.26 / + (+0.00%) 04/28/22 Fly Intel: Pre-market Movers 03/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/22/22 What You Missed On Wall Street On Tuesday 03/22/22 What You Missed On Wall Street This Morning LI Li Auto $18.91 / + (+0.00%) 05/02/22 What You Missed On Wall Street On Monday 05/02/22 What You Missed On Wall Street This Morning 05/02/22 What You Missed This Week in EVs and Clean Energy FCEL FuelCell $3.50 / +0.005 (+0.14%) 03/10/22 What You Missed On Wall Street On Thursday 03/10/22 What You Missed On Wall Street This Morning 12/29/21 Wall Street in Fives - Must Read Lists for Wednesday 12/29/21 Wall Street in Fives - Must Read Lists at Midday ACB Aurora Cannabis $2.53 / + (+0.00%) 05/05/22 Here's What You Missed in Cannabis, Psychedelics This Week 04/28/22 Here's What You Missed in Cannabis This Week 04/21/22 Rising High: Exclusive talk with psychedelics organization MAPS PBC 04/14/22 Here's What You Missed in Cannabis This Week 05/17/22 Best of Europe Virtual 1:1 Conference 06/01/22 50th Annual Technology, Media & Telecom Conference 05/10/22 Li Auto - LI 05/10/22 Vertex Energy - VTNR 05/11/22 Rivian Automotive - RIVN 05/12/22 Aurora Cannabis - ACB 07/28/22 Altria Group - MO 05/19/22 Altria Group Inc. 06/06/22 Rivian Automotive, Inc. 06/23/22 Vertex Energy, Inc. VTNR TBT RIVN NOK MO LI FCEL ACB VTNR Vertex Energy $9.49 / + (+0.00%) 05/05/22 Largest borrow rate increases among liquid names 04/19/22 Vertex Energy call volume above normal and directionally bullish 04/07/22 Largest borrow rate increases among liquid names 04/01/22 Vertex Energy call volume above normal and directionally bullish TBT ProShares UltraShort 20+ yr Trsry $26.76 / +0.005 (+0.02%) 05/03/22 Unusually active option classes on open May 3rd 04/27/22 Largest borrow rate increases among liquid names 04/14/22 Largest borrow rate increases among liquid names 01/10/22 Unusually active option classes on open January 10th RIVN Rivian Automotive $22.60 / + (+0.00%) 04/07/22 Rivian put volume heavy and directionally bearish 04/06/22 Largest borrow rate increases among liquid names 03/29/22 Rivian call volume above normal and directionally bullish 03/11/22 Notable open interest changes for March 11th NOK Nokia $4.78 / + (+0.00%) 04/28/22 Unusually active option classes on open April 28th 04/27/22 Nokia call volume above normal and directionally bullish 03/03/22 Unusually active option classes on open March 3rd 02/03/22 Unusually active option classes on open February 3rd MO Altria Group $55.26 / + (+0.00%) 03/22/22 Unusually active option classes on open March 22nd 03/11/22 Unusually active option classes on open March 11th 03/04/22 Unusually active option classes on open March 4th 02/22/22 Altria Group call volume above normal and directionally bullish LI Li Auto $18.91 / + (+0.00%) 05/06/22 Li Auto call volume above normal and directionally bullish 04/27/22 Unusually active option classes on open April 27th 03/14/22 Unusually active option classes on open March 14th 03/07/22 Li Auto call volume above normal and directionally bullish FCEL FuelCell $3.50 / +0.005 (+0.14%) 04/04/22 FuelCell call volume above normal and directionally bullish 03/08/22 FuelCell call volume above normal and directionally bullish 03/07/22 FuelCell call volume above normal and directionally bullish 02/28/22 Unusually active option classes on open February 28th ACB Aurora Cannabis $2.53 / + (+0.00%) 03/28/22 Unusually active option classes on open March 28th 03/25/22 Unusually active option classes on open March 25th 03/23/22 Unusually active option classes on open March 23rd 02/10/22 Aurora Cannabis options imply 12.2% move in share price post-earnings XLK EMB XLK Technology Select Sector SPDR $135.27 / + (+0.00%) 05/09/22 Technology Select Sector SPDR: Pivot points 05/06/22 Technology Select Sector SPDR: Pivot points 05/05/22 Technology Select Sector SPDR: Pivot points 05/04/22 Technology Select Sector SPDR: Pivot points EMB iShares JP Morgan USD Emerging Markets Bond ETF $88.55 / + (+0.00%) 04/01/22 On The Fly: ETF fund flow highlights 02/18/22 On The Fly: ETF fund flow highlights
On The Fly	Here's What You Missed in Cannabis, Psychedelics This Week » 11:42 05/05/22 05/05 11:42 05/05/22 11:42 GTBIF Green Thumb Industries $12.82 / -0.22 (-1.69%) , ETRGF Entourage Health / + , FFLWF Fire & Flower Holdings $2.66 / +0.09 (+3.50%) , CMPS Compass Pathways $9.11 / -0.39 (-4.11%) , WSNAF Wesana Health / + , TLRY Tilray $4.96 / -0.35 (-6.59%) , ACB Aurora Cannabis $2.95 / -0.25 (-7.82%) , CVSI CV Sciences / + , CTST CannTrust / + , CGC Canopy Growth $6.25 / -0.45 (-6.72%) , CRON Cronos Group $3.07 / -0.175 (-5.39%) , CANN General Cannabis / + , GDNSF Goodness Growth $1.65 / -0.02 (-1.20%) , IGC India Globalization Capital / + , TCNNF Trulieve Cannabis $13.75 / +0.01 (+0.07%) , ZYNE Zynerba $1.35 / -0.05 (-3.57%) , RLMD Relmada Therapeutics $23.27 / -0.96 (-3.96%) , ATAI Atai Life Sciences $4.04 / -0.35 (-7.97%) In this week's "Rising… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZYNE WSNAF TLRY TCNNF RLMD IGC GTBIF GDNSF ETRGF CVSI CTST CRON CMPS CGC ATAI ACB ZYNE Zynerba $1.35 / -0.05 (-3.57%) 05/02/22 Zynerba presents long-term safety, efficacy data of Zygel 04/18/22 Tela Bio appoints D. Taylor Ocasio as general counsel 02/28/22 Zynerba announces EC grants orphan drug designation for Zygel 02/28/22 Zynerba announces completion of enrollment in Phase 2 trial of Zygel WSNAF Wesana Health / + 05/05/22 Wesana Health to conduct strategic review of care delivery division 03/22/22 Wesana Health announces data from animal study of psilocybin 03/14/22 Wesana Health announces feedback from pre-IND meeting on SANA-013 02/02/22 Jones Soda, Wesana Health, Mike Tyson partner to launch nootropic supplement TLRY Tilray $4.96 / -0.35 (-6.59%) 04/12/22 HEXO, Tilray enter agreement for strategic alliance 04/12/22 Tilray enters agreement with HEXO related to Senior Secured Convertible Note 04/06/22 Tilray subsidiary Manitoba Harvest partners with Whole Foods Market 04/05/22 Tilray announces Solei brand launches cannabis edible in Quebec TCNNF Trulieve Cannabis $13.75 / +0.01 (+0.07%) 03/22/22 Tilt appoints Lynn Ricci as VP, investor relations, corporate communications 12/28/21 Trulieve appoints Steve White as president, Nicole Stanton as general counsel 12/28/21 Trulieve Cannabis acquires PurpleMed Healting Center in Arizona 11/29/21 Trulieve Cannabis issues first inaugural ESG report RLMD Relmada Therapeutics $23.27 / -0.96 (-3.96%) 04/29/22 Relmada Therapeutics announces publication of REL-1017 preclinical study 02/23/22 Relmada Therapeutics announces results from REL-1017 HAP study 12/22/21 Relmada Therapeutics: REL-1017 Phase 2 results published in AJOP IGC India Globalization Capital / + 12/08/21 India Globalization Capital says IGC-AD1 ph 1 trial provided 'valuable insight' 12/02/21 India Globalization Capital presents findings from Phase 1 trial of IGC-AD1 GTBIF Green Thumb Industries $12.82 / -0.22 (-1.69%) 05/02/22 Green Thumb announces internet availability of proxy materials for 2022 meeting 04/11/22 Green Thumb Industries to open RISE Mankato on April 14 03/11/22 Green Thumb Industries announces departure of Moore from board of directors 02/08/22 Green Thumb Industries appoints Dorri McWhorter to board of directors GDNSF Goodness Growth $1.65 / -0.02 (-1.20%) 02/28/22 Goodness Growth launches full line of cannabis flower in Minnesota 02/01/22 Verano Holdings to acquire Goodness Growth in $413M all-share transaction ETRGF Entourage Health / + 05/04/22 Entourage Health partners with Pineapple Express for same-day cannabis delivery 05/03/22 Entourage Health reaffirms preliminary 2021 revenue C$55.2M 03/25/22 Entourage Health launches 'Joints for Justice' retail campaign 03/24/22 Entourage Health updates timing for Q4, 2021 financials CVSI CV Sciences / + 03/08/22 CV Sciences adds +PlusCBD Relief Softgels to its Wellness line 01/11/22 CV Sciences launches +PlusCBD Pain Relief topicals 01/05/22 CV Sciences announces new distribution agreement with GNC 11/15/21 CV Sciences announces convertible note financing CTST CannTrust / + 01/06/22 CannTrust reports implementation of CCAA plan, settlement of lawsuits CRON Cronos Group $3.07 / -0.175 (-5.39%) 03/21/22 Cronos Group founder Mike Gorenstein returns as CEO 03/01/22 Cronos Group announces planned exit of Peace Naturals Campus in Ontario 02/18/22 Cronos Group announces strategic realignment for $20M-$25M in savings 02/18/22 Cronos Group completes Audit Committee evaluation CMPS Compass Pathways $9.11 / -0.39 (-4.11%) 05/03/22 Compass Pathways announces data on COMP360 psilocybin therapy 04/20/22 Compass Pathways partners with One Mind for Rising Star Awards 03/24/22 Compass Pathways, partners to launch psychedelic research facility 01/19/22 Compass Pathways announces results from survey conducted with Sermo on TRD CGC Canopy Growth $6.25 / -0.45 (-6.72%) 04/26/22 Canopy Growth expects to generate savings of $100M-$150M within 12-18 months 04/26/22 Canopy Growth announces cost reduction initiatives including headcount reduction 03/31/22 Canopy Growth appoints Judy Hong as CFO, Jonathan Di Tosto as COO 03/22/22 Canopy Growth announces results from trial using CBD on menstrual symptoms ATAI Atai Life Sciences $4.04 / -0.35 (-7.97%) 03/30/22 Atai Life Sciences reports Q4 net loss $88.9M vs. $86.6M a year ago 02/01/22 IntelGenx receives third loan tranche from Atai Life Sciences 01/27/22 Atai Life Sciences to partner with Dalriada 01/12/22 atai Life Sciences' IND for PCN-101 approved by FDA ACB Aurora Cannabis $2.95 / -0.25 (-7.82%) 03/22/22 Aurora Cannabis to acquire Thrive Cannabis for $38M 02/10/22 Aurora Cannabis reaffirms goal of adjusted EBITDA profitability by 1H2023 02/03/22 Aurora Cannabis' Reliva launches new product line, KG7 12/14/21 Aurora Cannabis and 22nd Century sign license agreement with Cronos Group GTBIF ETRGF FFLWF CMPS WSNAF TLRY ACB CVSI CTST CGC CRON CANN GDNSF IGC TCNNF ZYNE RLMD ATAI GTBIF Green Thumb Industries $12.82 / -0.22 (-1.69%) 05/05/22 Alliance Global Partners Green Thumb price target lowered to C$38 from C$40 at Alliance Global 05/05/22 Craig-Hallum Green Thumb Industries price target lowered to $25 from $35 at Craig-Hallum 05/05/22 Needham Green Thumb Industries price target lowered to $26 from $33 at Needham 04/01/22 Alliance Global Partners Senate remains the hurdle for MORE Act, says Alliance Global Partners ETRGF Entourage Health / + 11/18/21 Canaccord Entourage Health price target lowered to C$0.40 from C$0.60 at Canaccord 11/17/21 Canaccord Entourage Health price target lowered to C$0.40 from C$0.60 at Canaccord FFLWF Fire & Flower Holdings $2.66 / +0.09 (+3.50%) 04/28/22 Stifel Fire & Flower Holdings price target lowered to C$8.50 from C$12 at Stifel 12/15/21 Stifel Fire & Flower Holdings downgraded to Speculative Buy from Buy at Stifel 11/23/21 Cantor Fitzgerald Fire & Flower Holdings initiated with an Overweight at Cantor Fitzgerald 11/22/21 Cantor Fitzgerald Fire & Flower initiated with an Overweight at Cantor Fitzgerald CMPS Compass Pathways $9.11 / -0.39 (-4.11%) 02/28/22 Canaccord Compass Pathways price target lowered to $78 from $80 at Canaccord 11/11/21 Roth Capital Atai Life Sciences initiated with a Buy at Roth Capital 11/09/21 Citi Citi says Compass Pathways selloff overdone, ups price target to $70 11/09/21 Cantor Fitzgerald Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald WSNAF Wesana Health / + 04/01/22 Stifel Wesana Health initiated with a Speculative Buy at Stifel TLRY Tilray $4.96 / -0.35 (-6.59%) 05/02/22 Alliance Global Partners Tilray price target lowered to $5.50 from $8 at Alliance Global Partners 04/20/22 Barclays Tilray price target lowered to $4.50 from $8.50 at Barclays 04/06/22 MKM Partners Tilray margins contracted despite cost savings, says MKM Partners 04/06/22 Benchmark Tilray fiscal Q3 results 'disappointing,' says Benchmark ACB Aurora Cannabis $2.95 / -0.25 (-7.82%) 02/11/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald 02/03/22 CIBC Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC 11/11/21 Canaccord Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord CVSI CV Sciences / + 06/25/21 Alliance Global Partners Cannabis selloff brings buying opportunities, says Alliance Global CTST CannTrust / + CGC Canopy Growth $6.25 / -0.45 (-6.72%) 04/04/22 Morgan Stanley Constellation Brands price target lowered to $294 from $299 at Morgan Stanley 03/22/22 Barclays Canopy Growth downgraded to Underweight from Equal Weight at Barclays 03/01/22 Barclays Canopy Growth price target lowered to $9 from $14 at Barclays CRON Cronos Group $3.07 / -0.175 (-5.39%) 03/22/22 Barclays Cronos Group upgraded to Equal Weight from Underweight at Barclays 03/21/22 Stifel Stifel takes neutral overall view of Cronos' CEO transition 03/07/22 Piper Sandler Cronos Group price target lowered to $3 from $4 at Piper Sandler CANN General Cannabis / + GDNSF Goodness Growth $1.65 / -0.02 (-1.20%) 02/01/22 Craig-Hallum Goodness Growth downgraded to Hold from Buy at Craig-Hallum 11/11/21 Canaccord Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord IGC India Globalization Capital / + TCNNF Trulieve Cannabis $13.75 / +0.01 (+0.07%) 03/31/22 Canaccord Trulieve Cannabis price target lowered to C$65 from C$70 at Canaccord 03/30/22 Alliance Global Partners Trulieve Cannabis price target lowered to C$60 from C$76 at Alliance Global Partners 03/29/22 Cantor Fitzgerald Trulieve Cannabis price target lowered to $60 from $72 at Cantor Fitzgerald ZYNE Zynerba $1.35 / -0.05 (-3.57%) 05/06/21 Cantor Fitzgerald Zynerba price target raised to $8 from $6 at Cantor Fitzgerald RLMD Relmada Therapeutics $23.27 / -0.96 (-3.96%) 12/20/21 SVB Leerink Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink 11/17/21 Mizuho Relmada Therapeutics initiated with a Buy at Mizuho 09/30/21 Jefferies Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study 07/28/21 Truist Relmada Therapeutics price target raised to $90 from $75 at Truist ATAI Atai Life Sciences $4.04 / -0.35 (-7.97%) 04/01/22 Canaccord Atai Life Sciences price target lowered to $27 from $28 at Canaccord 03/31/22 RBC Capital Atai Life Sciences price target lowered to $9 from $12 at RBC Capital 11/30/21 Fly Intel: Top five analyst initiations 11/30/21 Maxim Atai Life Sciences initiated with a Buy at Maxim ZYNE TLRY RLMD GTBIF ETRGF CVSI CRON CMPS CGC ATAI ACB ZYNE Zynerba $1.35 / -0.05 (-3.57%) 03/01/22 Zynerba reports Q4 EPS (22c), consensus (26c) 11/15/21 Zynerba reports Q3 EPS (26c), consensus (25c) TLRY Tilray $4.96 / -0.35 (-6.59%) 04/06/22 Tilray reports Q3 EPS 9c vs. ($1.03) last year 01/10/22 Tilray reports Q2 revenue $155M vs. $129M last year RLMD Relmada Therapeutics $23.27 / -0.96 (-3.96%) 03/23/22 Relmada Therapeutics reports Q4 EPS ($1.80), consensus ($1.83) 11/11/21 Relmada Therapeutics reports Q3 EPS ($2.44), consensus ($1.60) GTBIF Green Thumb Industries $12.82 / -0.22 (-1.69%) 03/01/22 Green Thumb Industries reports Q4 EPS 10c vs. 11c last year ETRGF Entourage Health / + 04/22/22 Entourage Health reaffirms preliminary 2021 revenue C$54.8M 02/11/22 Entourage Health reports 2021 revenue C$54.8M, up 54% y-o-y 11/16/21 Entourage Health reports Q3 revenue C$14.9M vs. C$7.74M last year CVSI CV Sciences / + 11/15/21 CV Sciences reports Q3 EPS 0c vs. (3c) last year CRON Cronos Group $3.07 / -0.175 (-5.39%) 03/01/22 Cronos Group reports 2021 EPS ($1.07), consensus (47c) 02/18/22 Cronos Group reports Q3 EPS 21c, consensus (10c) CMPS Compass Pathways $9.11 / -0.39 (-4.11%) 02/24/22 Compass Pathways reports Q4 EPS (61c), consensus (50c) 11/09/21 Compass Pathways reports Q3 EPS (38c), consensus (49c) CGC Canopy Growth $6.25 / -0.45 (-6.72%) 04/07/22 Constellation Brands reports Q4 comparable EPS ex-Canopy losses $2.55 02/09/22 Canopy Growth reports Q3 EPS (C$0.28) vs. (C$2.43) a year ago ATAI Atai Life Sciences $4.04 / -0.35 (-7.97%) 11/15/21 Atai Life Sciences reports Q3 EPS (21c), consensus (20c) ACB Aurora Cannabis $2.95 / -0.25 (-7.82%) 02/10/22 Aurora Cannabis reports Q2 adjusted EBITDA (C$9M) vs. (C$11.5) in Q1 02/10/22 Aurora Cannabis reports Q2 revenue C$60.6M, vs. C$67.67M a year ago 01/04/22 Aurora Cannabis to deliver C$10M cannabis shipment to Israel 11/09/21 Aurora Cannabis reports Q1 revenue C$60.1M vs. C$67.59M last year 09 Dec 18 Jun GTBIF GTBIF Green Thumb Industries $12.82 / -0.22 (-1.69%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says 11/15/21 Republicans introduce cannabis legalization bill, Insider says WSNAF GTBIF FFLWF WSNAF Wesana Health / + 03/24/22 Here's What You Missed in Cannabis This Week 01/21/22 Rising High: Exclusive talk with mental health company Wesana GTBIF Green Thumb Industries $12.82 / -0.22 (-1.69%) 05/05/22 Here's What You Missed in Cannabis, Psychedelics This Week 04/28/22 Here's What You Missed in Cannabis This Week 04/21/22 Rising High: Exclusive talk with psychedelics organization MAPS PBC 04/14/22 Here's What You Missed in Cannabis This Week FFLWF Fire & Flower Holdings $2.66 / +0.09 (+3.50%) 12/16/21 Rising High: Canopy Growth divests subsidiary C3 12/09/21 Rising High: Fire & Flower to acquire Pineapple Express Delivery 05/24/22 6th Annual Future of the Consumer: Sustainable Growth for a New Ecosystem 05/05/22 Relmada Therapeutics - RLMD 05/10/22 Compass Pathways - CMPS 05/10/22 Cronos Group - CRON 05/12/22 Aurora Cannabis - ACB 05/16/22 Atai Life Sciences - ATAI 05/25/22 Relmada Therapeutics, Inc. 06/08/22 General Cannabis Corp. 06/14/22 Zynerba Pharmaceuticals, Inc. 06/16/22 COMPASS Pathways plc 06/16/22 Green Thumb Industries Inc. TLRY CRON CMPS CGC ATAI ACB TLRY Tilray $4.96 / -0.35 (-6.59%) 05/02/22 Put bomber drops one in Tilray 03/30/22 Tilray call volume above normal and directionally bullish 03/29/22 Largest borrow rate increases among liquid names 03/28/22 Unusually active option classes on open March 28th CRON Cronos Group $3.07 / -0.175 (-5.39%) 11/12/21 Cronos Group call volume above normal and directionally bullish 11/08/21 Cronos Group call volume above normal and directionally bullish CMPS Compass Pathways $9.11 / -0.39 (-4.11%) 11/09/21 Unusually active option classes on open November 9th CGC Canopy Growth $6.25 / -0.45 (-6.72%) 05/03/22 Canopy Growth put volume heavy and directionally bearish 04/29/22 Largest borrow rate increases among liquid names 04/25/22 Largest borrow rate increases among liquid names 04/19/22 Largest borrow rate increases among liquid names ATAI Atai Life Sciences $4.04 / -0.35 (-7.97%) 12/21/21 Largest borrow rate increases among liquid names 12/16/21 Largest borrow rate increases among liquid names ACB Aurora Cannabis $2.95 / -0.25 (-7.82%) 03/25/22 Unusually active option classes on open March 25th 03/23/22 Unusually active option classes on open March 23rd 02/10/22 Aurora Cannabis options imply 12.2% move in share price post-earnings

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial